Erland Sternby

Société Générale SA (UK) (Société Générale UK) is the Great Britain-based brokerage division of Societe Generale SA (XP: GLE, ADR: SCGLY) in France. Headquartered in London, Société Générale UK was founded in 1993 and provides broking services.

Dresdner Kleinwort Securities LLC (DKS) is the investment bank of Dresdner Bank AG and a member of Allianz SE (FR: ALV) in Germany. Headquartered in London and Frankfurt, and with an international network of offices, DKS provides a wide range of investment bank products and services to European and international clients through their Global Banking and Capital Markets business lines. DKS provides an integrated service across the spectrum of Capital Markets products, including Short Term Products & Treasury, Equity Products, Rates, Credit Products, Foreign Exchange, Debt Origination, Sales & Marketing, Research, and Risk Management & Tax. DKS offers general financial advice together with execution capability for a range of corporate finance related transactions on a global basis. The primary focus is on mergers and acquisitions, disposals, equity issues and initial public offerings.

ABN AMRO Bank NV, established in 1824, is an international bank based in Amsterdam ABN AMRO Bank NV, and a wholly-owned subsidiary of ABN AMRO Holding NV (XA: AABA; NYSE: ABN). The firm's investment banking business unit provides commercial clients in local markets as well as multinational corporations and financial institutions whit advisory, financing and operational services. They have global expertise in the international capital markets and eco-markets as well as for transaction banking, asset management and private equity.

Goetzpartners Securities Ltd. is the Great Britain-based brokerage subsidiary of goetzpartners Corporate Finance GmbH, which is owned by goetzpartners Holding GmbH & Co. KG in Germany. Headquartered in London, the firm was founded in 2003 to serve as a corporate broker for European healthcare companies. Goetzpartners Securities offers their corporate clients direct and well-established institutional buy-side access. They also provide access to high-net-worth individuals who are investing in healthcare sectors. Their equity sales team has broad geographic coverage, and offers specialist insight into healthcare capital markets.